PD-L1 is a known IGF2BP1 target mRNA in liver and bladder cancer.23,41 In HGSC cells, the depletion of IGF2BP1 consistently downregulated PD-L1 mRNA expression while enhancing IRF1-driven gene signatures (Fig. 5a). This evidence concerns the gene IRF1 and urinary bladder carcinoma.